Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zhao XY et al. | [Effects of BIO-1211 on eosinophil chemotaxis, recruitment and mediator release]. | 2003 | Zhejiang Da Xue Xue Bao Yi Xue Ban | pmid:12970925 |
Lamparter E and Lunkenheimer CH | The automation of dissolution testing of solid oral dosage forms. | 1992 Oct-Dec | J Pharm Biomed Anal | pmid:1298375 |
Cheng NN et al. | [The composition of phospholipid and biosynthesis of platelet-activating factor in earthworm (Eisenia foetida)]. | 1992 | Yao Xue Xue Bao | pmid:1299136 |
Wong B et al. | Identification of a membrane-associated 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine hydrolyzing phospholipase A2 in guinea pig 1 epidermis. Implications in the cutaneous biosynthesis of platelet-activating factor. | 1992 | FEBS Lett. | pmid:1299618 |
Wu QX | [Amplification and desensitization in platelet activation]. | 1992 | Sheng Li Ke Xue Jin Zhan | pmid:1299958 |
Doly M et al. | Inhibition of vincristine-induced retinal impairments by a specific PAF antagonist. | 1992 | Lens Eye Toxic Res | pmid:1301801 |
Nijkamp FP et al. | Reversal of the endotoxin-induced bronchial hyperreactivity to histamine by the platelet activating factor antagonist BN 52021. | 1992 | Pneumonol Alergol Pol | pmid:1305483 |
Hirano T and Manabe T | "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. | 1992 | Nihon Geka Hokan | pmid:1306981 |
Li Q | [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects]. | 1992 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:1307517 |
Klöcking HP | Inhibition of PAF-induced tPA release by KO-286011. | 1992 | Ann. N. Y. Acad. Sci. | pmid:1309038 |
Zoratti EM et al. | Platelet-activating factor primes human eosinophil generation of superoxide. | 1992 | Am. J. Respir. Cell Mol. Biol. | pmid:1309421 |
van Willigen G and Akkerman JW | Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin. | 1992 | Blood | pmid:1309427 |
Bratton DL et al. | The mechanism of internalization of platelet-activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane. | 1992 | J. Immunol. | pmid:1309560 |
Ono S and Voelkel NF | PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. | 1992 | Lung | pmid:1310128 |
Schwaner I et al. | Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways. | 1992 | Biochem. J. | pmid:1310589 |
Gandhi CR et al. | A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. | 1992 | Biochem. J. | pmid:1310601 |
Jagels MA and Hugli TE | Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. | 1992 | J. Immunol. | pmid:1310708 |
Földes-Filep E et al. | C-reactive protein inhibits intracellular calcium mobilization and superoxide production by guinea pig alveolar macrophages. | 1992 | J. Leukoc. Biol. | pmid:1311010 |
Yue TL et al. | Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. | 1992 | Mol. Pharmacol. | pmid:1311408 |
Grandoni KM et al. | Trichothecene mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. | 1992 | Toxicology | pmid:1311467 |
Wu T et al. | Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. | 1992 | Am. J. Respir. Cell Mol. Biol. | pmid:1311593 |
Catalán RE et al. | PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex. | 1992 | Biochem. Biophys. Res. Commun. | pmid:1311925 |
Shukla SD | Platelet-activating factor receptor and signal transduction mechanisms. | 1992 | FASEB J. | pmid:1312046 |
Aepfelbacher M et al. | Bacterial lipopolysaccharide up-regulates platelet-activating factor-stimulated Ca2+ mobilization and eicosanoid release in human Mono Mac 6 cells. | 1992 | J. Immunol. | pmid:1312103 |
Henson PM et al. | NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. | 1992 | Am. Rev. Respir. Dis. | pmid:1312316 |
Alonso MT et al. | Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets. | 1992 | Biochim. Biophys. Acta | pmid:1312357 |
Bazan NG | Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. | 2003 | J. Lipid Res. | pmid:13130128 |
Chatterjee SS et al. | Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. | 2003 | Pharmacopsychiatry | pmid:13130392 |
e Silva PM et al. | Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects. | 1992 | Br. J. Pharmacol. | pmid:1313729 |
Schaberg T et al. | Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. | 1992 | Eur. Respir. J. | pmid:1314191 |
Zhu YP et al. | The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. | 1992 | Am. J. Obstet. Gynecol. | pmid:1314480 |
Rabinovici R et al. | Platelet activating factor mediates interleukin-2-induced lung injury in the rat. | 1992 | J. Clin. Invest. | pmid:1314853 |
Zarco P et al. | Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. | 1992 | Clin. Exp. Immunol. | pmid:1315229 |
Kuijpers TW et al. | Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. | 1992 | J. Cell Biol. | pmid:1315317 |
Carveth HJ et al. | Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin. | 1992 | Semin. Thromb. Hemost. | pmid:1315452 |
Adler KB et al. | Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism. | 1992 | Am. J. Respir. Cell Mol. Biol. | pmid:1316134 |
Morland CM et al. | Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. | 1992 | Am. J. Respir. Cell Mol. Biol. | pmid:1316135 |
Koltai M et al. | Role of PAF and cytokines in microvascular tissue injury. | 1992 | J. Lab. Clin. Med. | pmid:1316420 |
Fukuchi Y et al. | Low ligand binding activities of two distinct types of Fc gamma receptor on guinea-pig peripheral blood polymorphonuclear leukocytes are differentially improved by proteolysis or platelet activating factor. | 1992 | Mol. Immunol. | pmid:1316550 |
Sehmi R et al. | Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. | 1992 | Blood | pmid:1316789 |
Pinckard RN et al. | Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor. | 1992 | J. Immunol. | pmid:1316919 |
Kimura K et al. | Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins. | 1992 | Biochem. J. | pmid:1317164 |
Joly F et al. | Biosynthesis of paf-acether in cultured-mouse mast cells: the role of calcium and G proteins. | 1992 | Biochem. Biophys. Res. Commun. | pmid:1317174 |
Moreira-Ludewig R and Healy CT | A rapid microtiter plate method for the detection of lysozyme release from human neutrophils. | 1992 | J Pharmacol Toxicol Methods | pmid:1317227 |
Smith LJ | Bioactive mediators in asthma. | 1992 | Chest | pmid:1317278 |
Graham RM et al. | Plasma platelet-activating factor degradation in patients with severe coronary artery disease. | 1992 | Clin. Sci. | pmid:1317763 |
Guinn DE et al. | Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists. | 1992 | J. Med. Chem. | pmid:1317924 |
Herbert JM | Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells. | 1992 | Biochem. J. | pmid:1318021 |
Hidi R et al. | Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro. | 1992 | J. Leukoc. Biol. | pmid:1318347 |
Rediske JJ et al. | Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products. | 1992 | J. Leukoc. Biol. | pmid:1318349 |